Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Yurika Ikeda-Dantsuji"'
Autor:
Ryohei Ogawa, Yukihiro Furusawa, Yurika Ikeda-Dantsuji, Zheng-Guo Cui, Ichiro Takasaki, Yoshiaki Tabuchi, Loreto B. Feril, Katsuro Tachibana, Kazuki Yamaguchi
Publikováno v:
Journal of Medical Ultrasonics. 48:451-461
Purpose To determine the effect of low-intensity ultrasound on cancer cell proliferation in vitro and tumor growth in vivo. Methods In vitro, several cancer cell lines were exposed to low-intensity ultrasound at 0.11 W/cm2 for 2 min. Of the cell line
Autor:
Yurika Ikeda-Dantsuji, Yuki Kinjo, Yoshitsugu Miyazaki, Minoru Nagi, Kazutoshi Shibuya, Tatsuya Inukai, Takashi Umeyama, Satoshi Yamagoe, Shigeki Nakamura, Hideaki Ohno, Keigo Ueno
Publikováno v:
Medical Mycology. 56:382-386
The efficacy of recombinant interferon γ (rIFN-γ) for cryptococcal meningoencephalitis has been poorly understood. Compared to Cryptococcus gattii, rIFN-γ significantly improved the survival in experimental meningoencephalitis due to Cryptococcus
Autor:
Shigeki Nakamura, Yoshitsugu Miyazaki, Yoshitsugu Higashi, Yurika Ikeda-Dantsuji, Minoru Nagi, Tatsuya Inukai, Lianjin Jin, Masahiro Abe, Makoto Urai
Publikováno v:
Antimicrobial Agents and Chemotherapy. 63
Cryptococcus gattii is a fungal pathogen, endemic in tropical and subtropical regions, the west coast of Canada, and the United States, that causes a potentially fatal infection in otherwise healthy individuals. Because the cryptococcal polysaccharid
Autor:
Shigeki, Nakamura, Yurika, Ikeda-Dantsuji, Lianjin, Jin, Yoshitsugu, Higashi, Masahiro, Abe, Tatsuya, Inukai, Minoru, Nagi, Makoto, Urai, Yoshitsugu, Miyazaki
Publikováno v:
Antimicrobial agents and chemotherapy. 63(6)
Cryptococcus gattii is a fungal pathogen, endemic in tropical and subtropical regions, the west coast of Canada, and the United States, that causes a potentially fatal infection in otherwise healthy individuals. Because the cryptococcal polysaccharid
Autor:
Yuriko Hirao1,2,3, Yurika Ikeda-Dantsuji1, Hidehito Matsui1, Masaki Yoshida4, Seiji Hori4, Keisuke Sunakawa2, Taiji Nakae1, Hideaki Hanaki1 hanaki@insti.kitasato-u.ac.jp
Publikováno v:
BMC Microbiology. 2012, Vol. 12 Issue 1, p69-78. 10p. 4 Black and White Photographs, 1 Diagram, 5 Charts.
Autor:
Hitomi Endo, Yurika Ikeda-Dantsuji, Ryo Suzuki, Yoshimi Harada, Koichi Ogawa, Kazuo Maruyama, Katsuro Tachibana, Loreto B. Feril
Publikováno v:
Ultrasonics Sonochemistry. 18:425-430
To investigate whether or not the combined ultrasound and antibiotic treatment is effective against chlamydial infection, a new ultrasound exposure system was designed to treat chlamydia-infected cells. First, the minimum inhibitory concentrations of
Autor:
Masato Nonoyama, Yuriko Hirao, Satoshi Iwata, Fuminori Sakai, Keisuke Sunakawa, Yoshitake Sato, Taiji Nakae, Hideaki Hanaki, Hironobu Akita, Yurika Ikeda-Dantsuji
Publikováno v:
Journal of Infection and Chemotherapy. 17:358-362
Bacterial meningitis is a serious problem in pediatric clinics and, therefore, needs urgent and empirical chemotherapy. We investigated 1,116 cases of empirical chemotherapy of patients aged older than 4 months from 1997 through 2008 by sending quest
Autor:
Yoshio Yamaguchi, Hideaki Hanaki, Chie Yanagisawa, Yurika Ikeda-Dantsuji, Takeo Hashimoto, Harunori Yazaki, Keiko Sugahara, Takashi Yanagisawa, Hiroki Kawajiri, Shizue Sato, Aki Ishizaki, Rika Tachihara-Sato, Yasuhisa Takahashi, Taro Ono, Yo Kageyama, Tomohumi Kawaguchi, Akihiko Tamura, Kazuhiko Hagane, Keisuke Sunakawa
Publikováno v:
Journal of Infection and Chemotherapy. 15:274-278
It was reported that some methicillin-resistant Staphylococcus aureus (MRSA) show resistance to vancomycin (VCM) and beta-lactam antibiotics; thus, they are termed beta-lactam antibiotic-induced VCM-resistant MRSA (BIVR). The VCM resistance of MRSA i
Publikováno v:
Ultrasonics. 48:253-259
Recently, there have been numerous reports on the application of non-thermal ultrasound energy for treating various diseases in combination with drugs. Furthermore, the introduction of microbubbles and nanobubbles as carriers/enhancers of drugs has a
Autor:
Yurika Ikeda-Dantsuji, Hideaki Hanaki, Fuminori Sakai, Chie Yanagisawa, Taiji Nakae, Kazunori Tomono, Yoshio Takesue, Junichi Honda, Yuriko Nonomiya, Akira Suwabe, Osanori Nagura, Katsunori Yanagihara, Hiroshige Mikamo, Kunihiko Fukuchi, Mitsuo Kaku, Shigeru Kohno, Koichiro Yoshida, Yoshihito Niki
Publikováno v:
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.
Limited use of linezolid for treating methicillin-resistant Staphylococcus aureus (MRSA) infection was approved in Japan in 2006. We report here the status of linezolid-resistant MRSAs in Japan. Eleven linezolid-resistant clinical isolates from 11 pa